Significance of hepcidin level assessment in the diagnosis of selected types of anaemia in childhood;Význam stanovení hladiny hepcidinu v diagnostice vybraných typů anémií v dětském věku

Transfuze a Hematologie Dnes

Volumn 18, Issue 2, 2012, Pages 58-65

  Pospiilova D ^a   Houda, J ^a   Holub, D ^a   Ludikova B ^a   Mojzikova R ^a   Pospisilova P ^a   Zidova Z ^a   Kaprl'aova K ^a   Horvathova M ^a   Hajduch M ^a   Dzubak P ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Anaemia of chronic diseases; Diamond Blackfan anaemia; Hepcidin; Inflammatory bowel disease; Iron deficiency anaemia; Proteomic analysis; Pyruvate kinase deficiency

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; HEPCIDIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLACKFAN DIAMOND ANEMIA; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENTERITIS; ERYTHROPOIESIS; FEMALE; HUMAN; INFANT; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; MALE; PRESCHOOL CHILD; PROTEOMICS; PYRUVATE KINASE DEFICIENCY; SCHOOL CHILD; THALASSEMIA;

EID: 84883476346     PISSN: 12135763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta; publikováno elektronicky 25. ledna 2012. DOI 10.1016/j.bbamcr.2012.01. 014.
2. Park CH, Valore E V, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806-7810.
3. Valore E.V., Ganz T. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol Dis 2008; 40: 132-138. (Pubitemid 350192311)
4. Ganz T, Nemeth E. Iron imports: IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 2006; 290: G199-G203.
5. Cherian S, Forbes DA, Cook A.G., et al. An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS ONE 2008; 3: e4030.
6. Nemeth E, Tuttle MS, Powelson J, et al Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its interna-lization. Science 2004; 306: 2090-2097.
7. Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med 2012; 366: 348-359.
8. Tanno T, Noel P, Miller JL Growth differentiation factor 15 in erythroid health and disease. Curr Opin Hematol 2010; 17: 184-190.
9. Ganz T, Olbina G, Girelli D., Nemeth E, Westerman M. Immuno-assay for human serum hepcidin. Blood 2008; 112: 4292-4297.
10. Young MF, Glahn RP, Ariza-Nieto M, et al. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. Am J Clin Nutr 2009; 89: 533-538.
11. Melis MA, Cau M, Congiu R., et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008; 93: 1473-1479.
12. Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythro-poiesis and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in ß-thalassemia. Hematol Oncol Clin North Am 2010; 24: 1089-1107.
13. Gardenghi S, Marongiu MF, Ramos P, et al Ineffective erythro-poiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 2007; 109: 5027-5035. (Pubitemid 46827803)
14. Ginzburg Y, Rivella S. ß-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011; 118: 4321-4330.
15. Kattamis A, Papassotiriou I, Palaiologou D., et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006; 91: 809-812. (Pubitemid 44014549)
16. Tamary H, Shalev H, Perez-Avraham G, et al. Elevated growth differentiation factor 15 expression in patients with congenital dyse-rythropoietic anemia type I. Blood 2008; 112: 5241-5244.
17. Casanovas G, Swinkels DW, Altamura S, et al Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J Mol Med (Berl) 2011; 89: 811-816.
18. Ramirez JM, Schaad O, Durual S., et al. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts. Br J Haematol 2009; 144: 251-262.
19. Vokurka M, Krijt J, Sulc K., Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006; 55: 667-674. (Pubitemid 46021227)
20. Zanella A, Bianachi P, Iurlo A., et al. Iron status and HFE genotype in erytrocyte pyruvate kinase deficiency: Study of Italian cases. Blood cells Mol Dis 2001; 27, 653-661. (Pubitemid 32757061)
21. Finkenstedt A, Bianchi P, Theurl I., et al. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency. Br J Haematol 2009; 144: 789-793.
22. Kazal LA Jr. Prevention of iron deficiency in infants and toddlers. Am Fam Physician 2002; 66: 1217-1225.
23. Lozoff B, Klein NK, Nelson E.C., McClish DK, Manuel M, Chacon ME Behavior of infants with iron-deficiency anemia. Child Dev 1998; 69: 24-36. (Pubitemid 128453689)
24. Nemeth E, Valore EV, Territo M, Schiller G., Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101: 2461-2463. (Pubitemid 36857598)
25. Oustamanolakis P, Koutroubakis IE, Kouroumalis EA Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis 2011; 5: 381-391.
26. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Malliaraki N., Sfiridaki A, Kouroumalis EA Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroente-rol Hepatol 2011; 23: 262-268.
27. Nagy J, Lakner L, Poór VS, et al. Serum prohepcidin levels in chronic inflammatory bowel diseases. J Crohns Colitis 2010; 4: 649-653.
28. Arnold J, Sangwaiya A, Bhatkal B., Geoghegan F, Busbridge M. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homeostasis. Eur J Gastroenterol Hepatol 2009; 21: 425-429.